| Open | 2.62 |
| Previous Close | 2.68 |
| Volume | 201.3 Thou. |
| Average Volume | 26.89 Thou. |
| Day's Range | 2.56 โ 2.64 |
| 52 Week Range | 1.465-8.48 |
| Market Cap | 53.36 Mil. |
| Moving Average (50) | 2.6206 |
| Moving Average (200) | 3.29109 |
| Earnings per Share (EPS) | 15 |
| Price/Earnings (PE) | 0.17133333333333334 |
| Shares Outstanding | 20.76 Mil. |
| Earnings Date | Mar 21, 2024 |
| Beta | 1.478 |
| Last Dividend | 0 |
EAR Latest News
|
|
|
|
|
|
|
|
|
|
EAR Business Model
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.
| About Eargo | |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Number of Employees | 243 |
| Website & Executive | |
| Website | https://eargo.com |
| CEO (Chief Executive Officer) | William H. Brownie |
| IPO date | 2020-10-16 |
| Contact | |
| Country | US |
| Address | 2665 North First Street |
| City | San Jose |
| State | CA |
| Phone | 650 351 7700 |
| Zip Code | 95134 |
| Other Identifiers | |
| CIK | 0001719395 |
| ISIN | US2700872086 |
| CUSIP | 270087109 |
